Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
NCT00308438
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn's Disease
Interventions
DRUG:
Teduglutide (ALX-0600)
Sponsor
Shire